World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
71
Citations
17152
World Ranking
2331
National Ranking
159

Udo S. Gaipl publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Udo S. Gaipl sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 310 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Udo S. Gaipl D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Udo S. Gaipl sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 71 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Udo S. Gaipl is affiliated with the University of Erlangen-Nuremberg in Germany and has made significant contributions in the field of Medicine, focusing predominantly on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, as well as Pulmonary and Respiratory Medicine. Their research encompasses various specialized fields and topics related to cancer and the immune system.

The scientist's main fields of study include:

  • Oncology
  • Immunology
  • Radiology, Nuclear Medicine and Imaging
  • Pulmonary and Respiratory Medicine
  • Molecular Biology

Gaipl's research topics span several areas, notably:

  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • Radiomics and Machine Learning in Medical Imaging
  • Lung Cancer Research Studies
  • Effects of Radiation Exposure
  • Lung Cancer Treatments and Mutations
  • Immune cells in cancer

They have published extensively in multiple venues, with frequent publications in:

  • Frontiers in Oncology
  • Strahlentherapie und Onkologie
  • Frontiers in Immunology
  • International Journal of Molecular Sciences
  • Laryngo-Rhino-Otologie

Recent papers by Udo S. Gaipl include:

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death, 2020, Journal for ImmunoTherapy of Cancer
  • Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis, 2020, Nature Communications
  • Radiotherapy and the immune system: More than just immune suppression, 2021, Stem Cells
  • Benchmarking ChatGPT-4 on a radiation oncology in-training exam and Red Journal Gray Zone cases: potentials and challenges for ai-assisted medical education and decision making in radiation oncology, 2023, Frontiers in Oncology
  • Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells, 2020, Journal for ImmunoTherapy of Cancer

Udo S. Gaipl collaborates frequently with other researchers. Notable co-authors include:

  • Benjamin Frey
  • Rainer Fietkau
  • Markus Hecht
  • Jian-Guo Zhou
  • Sabine Semrau

Best Publications

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Lorenzo Galluzzi;Ilio Vitale;Sarah Warren;Sandy Adjemian

  • Consensus guidelines for the detection of immunogenic cell death

    Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli

  • Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus.

    Irith Baumann;Wasilis Kolowos;Reinhard E. Voll;Bernhard Manger

  • Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis

    Narges Tajik;Michael Frech;Oscar Schulz;Fabian Schälter

  • Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

    Abhishek D. Garg;Lorenzo Galluzzi;Lionel Apetoh;Lionel Apetoh;Thais Baert

  • Clearance deficiency and systemic lupus erythematosus (SLE).

    Udo S. Gaipl;Luis E. Munoz;Gerhard Grossmayer;Kirsten Lauber

  • Old and new facts about hyperthermia-induced modulations of the immune system.

    Benjamin Frey;Eva-Maria Weiss;Yvonne Rubner;Roland Wunderlich

  • SLE—a disease of clearance deficiency?

    L. E. Munoz;U. S. Gaipl;S. Franz;A. Sheriff

  • Impaired clearance of dying cells in systemic lupus erythematosus

    Udo S. Gaipl;Reinhard E. Voll;Ahmed Sheriff;Sandra Franz

  • Etiopathogenesis of Systemic Lupus Erythematosus

    Martin Herrmann;Thomas Winkler;Udo Gaipl;Hanns-Martin Lorenz

  • Sodium Overload and Water Influx Activate the NALP3 Inflammasome

    Christine Schorn;Benjamin Frey;Kirsten Lauber;Christina Janko

  • Phospholipids: Key Players in Apoptosis and Immune Regulation

    Ricardo A. Chaurio;Christina Janko;Luis E. Muñoz;Benjamin Frey

  • Modulation of Inflammatory Immune Reactions by Low-Dose Ionizing Radiation: Molecular Mechanisms and Clinical Application

    F. Rodel;B. Frey;U. Gaipl;L. Keilholz

  • Inhibition of Phosphatidylserine Recognition Heightens the Immunogenicity of Irradiated Lymphoma Cells In Vivo

    Attilio Bondanza;Valérie S. Zimmermann;Patrizia Rovere-Querini;Javier Turnay

  • Etiopathogenesis of systemic lupus erythematosus

    Martin Herrmann;Reinhard E Voll;Joachim R Kalden

  • Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death.

    U S Gaipl;S Kuenkele;R E Voll;T D Beyer

  • Role of apoptosis in autoimmunity.

    H M Lorenz;M Herrmann;T Winkler;U Gaipl

  • Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases.

    Benjamin Frey;Michael Rückert;Lisa Deloch;Paul F. Rühle

  • The Immune System in Cancer Prevention, Development and Therapy.

    Serge M Candeias;Udo S Gaipl

  • Antitumor immune responses induced by ionizing irradiation and further immune stimulation

    Benjamin Frey;Yvonne Rubner;Lorenz Kulzer;Nina Werthmöller

  • Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors.

    Anja Derer;Benjamin Frey;Rainer Fietkau;Udo S. Gaipl

Frequent Co-Authors

Benjamin Frey
Benjamin Frey University of Erlangen-Nuremberg
Rainer Fietkau
Rainer Fietkau University of Erlangen-Nuremberg
Martin Herrmann
Martin Herrmann University of Erlangen-Nuremberg
Reinhard E. Voll
Reinhard E. Voll University of Freiburg
Franz Rödel
Franz Rödel Goethe University Frankfurt
Joachim R. Kalden
Joachim R. Kalden University of Erlangen-Nuremberg
Luis E. Muñoz
Luis E. Muñoz University of Erlangen-Nuremberg
Georg Schett
Georg Schett University of Erlangen-Nuremberg
Gabriele Multhoff
Gabriele Multhoff Technical University of Munich
Kirsten Lauber
Kirsten Lauber Ludwig-Maximilians-Universität München

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying Immunology in the USA, exploring related online degrees can open multiple career pathways. Many students transition from foundational healthcare roles into specialized fields, such as moving from a family nurse practitioner (FNP) to acute care roles. Programs highlighting how to transition from fnp to acute care np provide valuable guidance for this career shift.

Accelerated programs are also popular among professionals seeking to advance quickly. For example, enrolling in a nurse practitioner accelerated program enables faster completion without compromising educational quality.

Moreover, those without prior nursing experience can access flexible learning options. Online programs such as online rn programs for non nurses in florida equip students with the necessary skills to enter nursing fields closely allied with immunology.

For students aiming to enter nursing sooner, many seek out accelerated nursing programs which balance rigorous training with more accessible admission criteria. These diverse pathways ensure a strong workforce that supports immunology research and patient care.

Best Scientists Citing Udo S. Gaipl

Trending Scientists

Recently Published Articles